NOS3 signaling inhibits the beta-adrenergic response by reducing L-type Ca2+ current, protecting against arrhythmias, as evidenced by increased EADs and aftercontractions with NOS3 inhibition (P<0.05).
Does NOS3 signaling decrease beta-adrenergic responsiveness and protect against arrhythmias in mouse myocytes?
NOS3 signaling inhibits the beta-adrenergic response by reducing L-type Ca2+ current, providing a mechanism for protection against arrhythmias.
p-value: p=<0.05
Signaling via endothelial nitric oxide synthase (NOS3) limits the heart's response to beta-adrenergic (beta-AR) stimulation, which may be protective against arrhythmias. However, mechanistic data are limited. Therefore, we performed simultaneous measurements of action potential (AP, using patch clamp), Ca2+ transients (fluo 4), and myocyte shortening (edge detection). L-type Ca2+ current (ICa) was directly measured by the whole cell ruptured patch-clamp technique. Myocytes were isolated from wild-type (WT) and NOS3 knockout (NOS3-/-) mice. NOS3-/- myocytes exhibited a larger incidence of beta-AR (isoproterenol, 1 microM)-induced early afterdepolarizations (EADs) and spontaneous activity (defined as aftercontractions). We also examined ICa, a major trigger for EADs. NOS3-/- myocytes had a significantly larger beta-AR-stimulated increase in ICa compared with WT myocytes. In addition, NOS3-/- myocytes had a larger response to beta-AR stimulation compared with WT myocytes in Ca2+ transient amplitude, shortening amplitude, and AP duration (APD). We observed similar effects with specific NOS3 inhibition L-N5-(1-iminoethyl)-ornithine (l-NIO), 10 microM in WT myocytes as with NOS3 knockout. Specifically, l-NIO further increased isoproterenol-stimulated EADs and aftercontractions. l-NIO also further increased the isoproterenol-stimulated ICa, Ca2+ transient amplitude, shortening amplitude, and APD (all P < 0.05 vs isoproterenol alone). l-NIO had no effect in NOS3-/- myocytes. These results indicate that NOS3 signaling inhibits the beta-AR response by reducing ICa and protects against arrhythmias. This mechanism may play an important role in heart failure, where arrhythmias are increased and NOS3 expression is decreased.
Wang et al. (Sat,) conducted a other in Arrhythmias. NOS3 knockout or NOS3 inhibition (l-NIO) with beta-adrenergic stimulation (isoproterenol) vs. Wild-type myocytes / isoproterenol alone was evaluated on L-type Ca2+ current (ICa), early afterdepolarizations (EADs), and spontaneous activity (p=<0.05). NOS3 signaling inhibits the beta-adrenergic response by reducing L-type Ca2+ current, protecting against arrhythmias, as evidenced by increased EADs and aftercontractions with NOS3 inhibition (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: